Fiona Thomson joined the Institute of Cancer Sciences, University of Glasgow, early November 2014 as the Director of the Translational Pharmacology Laboratory within the Glasgow Experimental Cancer Medicine Centre (ECMC). Her group’s research aims to leverage new discoveries in cancer sciences to improve the treatment of patients. The Translational Pharmacology Laboratory applies state-of-the–art technologies to discover and develop novel measures (‘biomarkers’) to aid early cancer diagnosis, cancer prognosis and to support the development of novel cancer therapies through clinical trials. Prior to joining the University of Glasgow, Fiona spent over 15 years within the pharmaceutical industry, latterly at Merck in the USA as Director of Early Development/Discovery Sciences, leading drug discovery programmes. Fiona is a graduate of the University of Edinburgh, where she gained both BSc and PhD degrees in pharmacology.